Table 1.
ICH features | Crude |
Adjusted |
||||||
---|---|---|---|---|---|---|---|---|
β | 95% CI | p value | β | 95% CI | p value | |||
Lobar location | –2.190 | –3.194 | –1.185 | <0.001 | 0.2419 | –0.7648 | 1.2485 | 0.6376 |
Volume, mL | –2.994 | –3.259 | –2.729 | <0.001 | –3.3039 | –3.6371 | –2.9707 | <0.001 |
Irregular shape | –0.575 | –1.176 | 0.027 | 0.061 | 1.8723 | 1.2903 | 2.4542 | <0.001 |
Heterogenous density | –1.654 | –2.268 | –1.040 | <0.001 | 0.1273 | –0.4607 | 0.7153 | 0.6712 |
Intraventricular extension | –0.751 | –1.413 | –0.090 | 0.026 | –0.0607 | –0.6788 | 0.5573 | 0.8472 |
Subarachnoid extension | –4.115 | –5.202 | –3.028 | <0.001 | –1.4648 | –2.5513 | –0.3782 | 0.0083 |
White matter lesion | 0.871 | 0.264 | 1.479 | 0.005 | 0.6500 | 0.0803 | 1.2197 | 0.0254 |
Atrophy | 0.434 | –0.355 | 1.223 | 0.281 | –0.4020 | –1.2034 | 0.3994 | 0.3254 |
CI, confidence interval. Volume data were log transformed. Model adjusted for age, sex, ethnicity, high National Institutes of Health Stroke Scale score (<14 vs. ≥14), and history of ischemic stroke, hypertension, and antithrombotic use.